The extracellular matrix (ECM) provides the 'scaffolding' within a tissue to which cells attach, and contains domains that bind to specific cell surface receptors to modulate cellular activity. Remodelling of the ECM is a prerequisite for many physiological and pathological processes. Examples of ECM remodelling by matrix metalloproteinases (MMPs) during normal physiological processes within the reproductive system include follicular growth, ovulation, corpus luteum formation and regression, endometrial remodelling at menstruation, blastocyst outgrowth, trophoblast invasion, uterine involution, and mammary growth and involution. Examples of MMP involvement in pathological ECM remodelling include wound healing, osteoarthritis, breast carcinoma, and other forms of tumour cell metastasis. Two families of enzymes involved in remodelling of ECM are the matrix metalloproteinase (MMP) family and the plasminogen activator-plasmin family. The role of the plasminogen activator-plasmin family in ovarian function has been reviewed by Ny et al. (1993) . The focus of the present review is the role of MMPs and tissue inhibitors of metalloproteinases (TIMPs) in ovarian ECM remodelling and the subsequent effects on ovarian function.
Matrix metalloproteinases
Matrix metalloproteinases are zinc-and calcium-dependent enzymes that are largely responsible for degrading ECM proteins (Mignatti and Rifkin, 1993) . While sharing certain structural and biochemical properties, individual family members differ in their specificity for ECM components. However, all ECM proteins can be degraded by an appropriate complement of MMPs. Twelve members of the MMP family of enzymes have been characterized to date (Table 1) . Although most MMPs appear to be secreted, two membrane bound MMPs, which preferentially activate MMP-2 (gelatinase A), are also known (Sato et al., 1994; Takino et al., 1995) . Matrix metalloproteinases are secreted as latent proenzymes which are activated by proteolytic cleavage of an N-terminal peptide. ProMMPs are activated in vivo by serine proteases (plasminogen activator and kallikriens; Espey, 1992) , mast cell proteases (Suzuki et al., 1995) , and other MMPs including plasma membrane MMPs (Sato et al., 1994) .
The expression of proMMP genes is subject to control during transcription, translation and by changes in mRNA stability (Fig. 1) . Further control points are at the activation of secreted proenzymes by proteolytic cleavage of an N-terminal propeptide, and the association and dissociation of MMPs with specific inhibitors (Fig. 1) . Another way in which ECM remodelling can be regulated spatially and temporally is illustrated by the observation that MMP-2 is localized to the plasma membrane of invasive cells by association with an integrin (Brooks et al., 1996) .
Tissue inhibitors of metalloproteinases
Inhibitors of MMP activity include liver-derived, serum borne α 2 -macroglobulin and TIMPs. The activities of MMPs are regulated by a family of TIMPs, which includes TIMP-1, TIMP-2, TIMP-3 and TIMP-4 (Table 2 ). All TIMPs share 12 cysteine residues which are believed to form six disulfide bonds that arrange the molecule into two distinct domains. Despite similar structural properties, TIMP-1, -2, -3, and -4 differ in size, glycosylation, and expression in vitro and in vivo. Although they are separate gene products, each TIMP inhibits most members of the MMP family by noncovalent binding with a 1:1 stoichiometry and high affinity (K i value < 10 -9 mol 1 -1 ; Willenbrock and Murphy, 1994) .
The extent of ECM remodelling depends upon the ratio of active MMPs to TIMPs. A ratio in favour of MMP activity results in ECM degradation, whereas a ratio favouring TIMPs inhibits ECM degradation and is permissive for ECM deposition. The molecular interactions between TIMPs and MMPs have been studied extensively but much less is known about the post-secretory mechanisms regulating the activity of TIMPs. Growth and ovulation of follicles, and development, maintenance, and regression of the corpus luteum depend on cyclical remodelling of the extracellular matrix. The extracellular matrix consists of proteinaceous and non-proteinaceous components and provides the tissue-specific, extracellular architecture to which cells attach, and modulates the activities of cells through cell surface receptors. Specific components of the extracellular matrix are cleaved by matrix metalloproteinases, the activities of which are inhibited by tissue inhibitors of metalloproteinases. This review presents evidence for the involvement of matrix metalloproteinases and their inhibitors in extracellular matrix remodelling associated with ovarian function.
been fully investigated. Factors regulating the function of TIMP-1 include: (1) endothelial-stimulating angiogenesis factor (ESAF), a low molecular mass substance that liberates active MMP-1 from MMP-1-TIMP-1 complexes (McLaughlin et al., 1991) ; (2) proteinases (Itoh and Nagase, 1995); and (3) peroxynitrite, a product of superoxide radicals and hydrogen peroxide (Frears et al., 1996) . TIMPs are multifunctional molecules that, in addition to inhibiting MMP activity, stimulate proliferation of various cell types (Edwards et al., 1996) , and stimulate progesterone production by steroidogenic cells (Boujrad et al., 1995) . The mechanism by which TIMPs stimulate cell proliferation is unknown but may involve plasma membrane receptors (Edwards et al., 1996) .
Follicular growth
Follicular growth requires proliferation of theca and granulosa cells as well as expansion of the basement membrane within the confines of the ovarian stroma. For example, the development of a bovine primordial follicle (diameter = 0.1 mm) into a preovulatory follicle (diameter = 19 mm) requires approximately a 36 000-fold increase in follicular surface area. MMPs and TIMPs are obvious candidates for modulating the expansion of the follicular basement membrane and ECM remodelling within the theca interna, including during angiogenesis. The collagenous components of the ovarian stroma include interstitial collagens (types I and III), whereas collagen type IV is the collagenous component of the basement membrane (Luck, 1994) . Interstitial collagenase (MMP-1) occurs in theca and granulosa cells at all stages of follicular growth from primordial to Graafian follicles (Tadakuma et al., 1993) .
Growth factors participate in the proliferation and differentiation of ovarian follicular cells and are often constitutively expressed (Logan and Hill, 1992) . Growth factors, including fibroblast growth factor, transforming growth factor β, platelet derived growth factor and hepatocyte growth factor, and growth factor binding proteins, including insulin-like growth factor binding protein, contain motifs that bind to components of the ECM. Growth factors bound to ECM are biologically inactive and must be liberated, and occasionally activated, before binding to receptors (Logan and Hill, 1992) . Matrix metalloproteinases have been implicated in the regulation of growth factor and cytokine availability in that MMPs degrade insulinlike growth factor binding protein 3 (Fowlkes et al., 1994) and release active tumour necrosis factor α by processing its proform (Gearing et al., 1995; Moss et al., 1997) . Interactions between components of the ECM and growth factors increase their stability, concentrate them near the surface of specific cells, protect them from proteolysis, and alter their biological activity (Flaumenhaft and Rifkin, 1992) . Therefore, it seems that the regulated proteolytic degradation of the ECM may provide an important mechanism for regulating growth factor availability and activity during follicular growth.
Ovulation
The preovulatory gonadotrophin surge initiates a cascade of proteolytic activity within the preovulatory follicular wall that resembles an inflammatory response (Espey, 1992 (Espey, , 1994 . The apex region of the preovulatory follicular wall consists of granulosa cells, basement membrane, theca interna, theca externa, tunica albuginea, and superficial epithelium with its underlying basement membrane. The tensile strength of the follicular wall is determined by its collagen content. After a preovulatory gonadotrophin surge, ovarian collagenase activity increases (Curry et al., 1985; Hirsch et al., 1993) and collagen degradation is greatest in the apical region of the preovulatory follicular wall (Murdoch and McCormick, 1992) . Within the stigma region, proteolytic degradation of collagenous fibres progressively weakens the follicular wall and this, in conjunction with moderate and constant intrafollicular pressure, culminates in follicular rupture (Espey, 1994) . 
Role of matrix metalloproteinases
The synthesis of proteolytic enzymes (MMPs and plasminogen activators), which degrade ECM components of the preovulatory follicular wall, increases after the preovulatory gonadotrophin surge (Espey, 1992 (Espey, , 1994 . In rodents, there is evidence that only increased MMP activity is required for follicular rupture since ovulation occurs in the absence of plasminogen activator activity (Carmeliet et al., 1994) and inhibitors of MMPs block follicular rupture (Woessner et al., 1989) . Since the triple helical structure of interstitial collagen fibres (type I and III) is resistant to proteolytic degradation, interstitial collagenase (MMP-1) is probably essential for the initial degradation of fibrillar collagen in the tunica albuginea and theca layer. In support of this view, expression of the gene encoding ovarian MMP-1 increases after treatment with hCG or LH (Reich et al., 1991) and is related to collagen breakdown within the wall of the preovulatory follicle (Reich et al., 1985) . Furthermore, immunocytochemical studies in rabbits have shown that after hCG treatment the intensity of pro-MMP-1 labelling increases within theca and granulosa cells surrounding the orifice of the ruptured follicle. Immunoreactive proMMP-1 is localized to capillary lumina within the apex but not the basal regions of periovulatory follicles (Tadakuma et al., 1993) .
In addition to fibrillar collagen, the follicular wall contains a mesh-like network of collagen type IV within the basement membranes underlying the granulosa layer and superficial epithelium. Proteolytic enzymes that degrade collagen type IV include type IV gelatinases (72 kDa gelatinase (MMP-2) and 92 kDa gelatinase (MMP-9)) and stromelysin-1 (MMP-3). Gelatinase activity has been detected within preovulatory follicles of several species (Curry et al., 1992; Russell et al., 1995) . In rats, the expression (Reich et al., 1991) and activity (Curry et al., 1992) of the gene encoding MMP-2 increases after hCG injection, and treatment with interleukin 1β (which has been implicated in the ovulatory process) increases MMP-9 activity within preovulatory follicles (Hurwitz et al., 1993) . To our (4) involves proteolytic processing by plasmin generated by serum-derived plasminogen from locally produced activators, tissue plasminogen activator (tPA) and urokinase plasminogen activator (uPA). Proteolytically active MMPs (proMMPs) and membrane bound MMPs (membrane type MMPs, mtMMP) also activate proMMPs. MMPs degrade the proteinaceous components of the extracellular matrix (ECM) and the degree of ECM degradation is regulated primarily by locally produced inhibitors (5), including tissue inhibitors of metalloproteinases (TIMPs) and, possibly, the serum-derived inhibitor α 2 -macroglobulin (α 2 -MG). Degradation of the ECM can be localized to the cell surface by the association of MMP-2 with an integrin (6).
knowledge, MMP-3 has not been detected within ovarian follicles. A preovulatory increase in gelatinase activity within follicular fluid may be important for follicular rupture. Immunization of ewes against the N-terminal peptide of the 43 kDa inhibin α subunit (αN) is associated with reduced oviductal recovery of oocytes and formation of corpora lutea possessing a morphology consistent with incomplete basement membrane breakdown (Russell et al., 1995) . Inadequate breakdown of the basement membrane is associated with decreased gelatinase activity and MMP-2 concentrations within the follicular fluid of ewes immunized against αN (Russell et al., 1995) . Basement membrane breakdown around the time of follicular rupture is necessary for migration of endothelial cells (angiogenesis), fibroblasts, and luteinizing thecal cells during corpus luteum formation.
Role of inhibitors of matrix metalloproteinases
Initial attempts to detect MMP activity within periovulatory ovarian tissues were unsuccessful owing to the presence of MMP inhibitors, including TIMPs and α 2 -macroglobulin. α 2 -Macroglobulin is a large protein (720 000 kDa) that inhibits four major classes of proteinases, including MMPs, and is found in serum. During the periovulatory period, as a result of increased capillary permeability, α 2 -macroglobulin derived from serum may enter the extracellular spaces within the preovulatory follicle to assist in the regulation of collagenolysis.
After the preovulatory gonadotrophin surge in sheep, expression of the mRNA encoding TIMP-1 (Smith et al., 1994a) increases approximately tenfold and immunolabelled TIMP-1 is localized primarily in the granulosa cells of preovulatory follicles (McIntush et al., 1996) . Follicular fluid concentrations of TIMP-1 increase approximately tenfold after a gonadotrophin surge (McIntush et al., in press ). Conversely, expression of mRNA encoding TIMP-2 within ovine preovulatory follicles is not affected by the gonadotrophin surge, and TIMP-2 is localized to the thecal layer (Smith et al., 1995) . These differences in the localization and temporal expression of ovine TIMP-1 and -2 suggest that the regulation and potential functions of these MMP inhibitors differ, thus adding to the complexity of the control of proteolytic degradation within the follicular wall.
Regulation of follicular rupture
Before follicular rupture, collagen degradation occurs at the apex of the preovulatory follicular wall (Espey, 1967; Murdoch and McCormick, 1992) . This increase in collagen degradation may be caused by an increase in the ratio of MMP activity: inhibitor activity. At the time of follicular rupture, high concentrations of TIMP-1, and possibly α 2 -macroglobulin, within follicular fluid may neutralize MMP activity within the apex region of the follicular wall (Curry et al., 1989) . A more complete understanding of connective tissue remodelling within the stigma region of the preovulatory follicle awaits further investigation of the temporal and spatial expression, production and regulation of follicular MMPs and TIMPs.
Oocyte maturation and early embryonic development
In addition to regulating collagenolysis, increased concentrations of TIMP-1 in follicular fluid during the periovulatory period may affect oocyte maturation and early embryonic development. Collagenase, stromelysin and TIMP expression have been detected in unfertilized oocytes, zygotes, cleavage stage embryos and blastocysts (Brenner et al., 1989) . Furthermore, the addition of TIMP-1 during maturation of pig oocytes in vitro (Funahashi et al., 1997) or development of bovine embryos in vitro (Satoh et al., 1994) enhances early embryonic development. Mechanisms by which TIMP-1 enhances early embryonic development are unclear but may include regulation of ECM remodelling and stimulation of cellular proliferation.
Luteal development
The transition of the postovulatory follicle into a corpus luteum involves extensive ECM remodelling to accommodate the rapid proliferation (Jablonka-Shariff et al., 1993) , differentiation (Smith et al., 1994b) , and migration (O'Shea et al., 1980) of cells during luteal development (Box 1). Many migrating and proliferating cells are endothelial cells (Jablonka-Shariff et al., 1993) . In addition to endothelial cells and fibroblasts (Farin et al., 1986) , the corpus luteum contains two biochemically, physiologically, and morphologically distinct steroidogenic cell types: large luteal cells (LLCs), presumably derived from follicular granulosa cells, and small luteal cells (SLCs), presumably derived from follicular theca cells (Alila and Hansel, 1984) . The bulk of
Box 1. The extracellular matrix actively modulates cell function
Collagens, of which there are at least 18 types, are the major protein components of most extracellular matrices and form the primary scaffold to which other proteinaceous and nonproteinaceous components associate. Laminins, fibronectin, vitronectin, nigoden, perlecan and fubulin-1 are some of the proteins that associate either directly or indirectly with collagens. The collagen type(s) and the mixture of other proteinaceous and non-proteinaceous components vary between and within tissues and, thereby, provide for the requirements of specific cells within tissues. Extracellular matrices are not inert. They modulate cell function actively through cell surface receptors for extracellular matrix components. Integrins are one class of cell surface receptors. Integrins are heterodimers containing an α-and β-subunit. There are 14 α-subunits (α 1 -α 8 , α E , α iib , α L , α M , α V and α X ) and eight β-subunits (β 1 -β 8 ) that associate in different combinations to form at least 20 distinct integrins which differ in ligand binding. Interactions between integrins and extracellular matrix ligands activate a variety of intracellular signalling molecules including tyrosine, serinethreonine, and lipid kinases and phospholipases. In addition, binding of integrins to their respective ligands modulates the generation of second messengers by growth factors, cytokines and hormones.
The influence of the extracellular matrix on cell function is pronounced in tissues undergoing remodelling. Within these tissues, cells are exposed to different ligands for integrins as extracellular matrix components are degraded and replaced. Differentiation of cells into subsequent cell types, such as granulosa cells into large luteal cells, is likely to require sequential exposure to different extracellular matrix environments. luteal progesterone (80%) is derived from LLCs (Niswender et al., 1985) . The construction and degradation of the ECM associated with luteal cell differentiation and regression in vivo, together with the experimental evidence that ECM components enhance luteinization of follicular cells and that loss of ECM results in luteal cell death or loss of differentiated phenotype, are summarized (Fig. 2) . Remodelling of the ECM involves expression of genes encoding MMPs and inhibitors of ECM degrading proteases (TIMP-1, TIMP-2, TIMP-3 and PAI-1). The production of mRNA encoding TIMP-1 (Hampton et al., 1995) and TIMP-1 (McIntush and Smith, 1997) by the corpus luteum is 30-3 000 times greater than that of other tissues. Although reports of growth- (Edwards et al., 1996) and steroidogenesispromoting (Boujrad et al., 1995) activities of TIMP-1 suggest that it may also modulate these processes within the corpus luteum, the potential role of these activities will not be addressed here. TIMP-1, TIMP-2 and PAI-1 are expressed specifically by one of the several types of luteal cell, and may be important in maintaining an ECM microenvironment conducive to the differentiation of follicular-derived cells into luteal cells, and the maintenance of the phenotype of luteal cells.
Differentiation of granulosa cells into luteal cells is promoted by two components of the basal lamina, fibronectin or laminin, and blocked by an antibody to the integrin β 1 subunit (Aten et al., 1995) . Thus, it is likely that the luteal ECM is involved in manifestation of the phenotype of LLCs. In addition, inhibition of ECM degradation by inhibitors of MMPs can maintain the differentiated phenotype of epithelia (Alexander et al., 1996) . Thus, protease inhibitors may maintain the proper contacts between luteal cells and the ECM.
The mRNA encoding TIMP-1 is expressed in abundance during luteal development (Smith et al., 1994a) , a time when neovascularization and cell migration is rapid (Jablonka-Shariff et al., 1993) . These data indicate an apparent paradox since TIMP-1 inhibits neovascularization and cell migration (Khokha, 1994) presumably by inhibiting MMPs. An explanation might be that the concentration of mRNA encoding TIMP-1 is not indicative of the concentration of TIMP-1 protein in the extracellular milieu at this time. While the concentration of the mRNA encoding TIMP-1 per unit of DNA decreases (Freudenstein et al., 1990; Smith et al., 1994a Smith et al., , 1996 from the early to the mid-luteal phase, TIMP-1 mg -1 of luteal tissue increases approximately threefold from the early to the mid-luteal phase (McIntush and Smith, 1997) . Morphologically, the secretory granules in LLCs in which TIMP-1 is localized (McIntush et al., 1996) fit the criteria for dense core secretory granules, which are often associated with a regulated pathway of protein secretion (Kelly, 1985) . Thus, increasing TIMP-1 protein, decreasing mRNA encoding TIMP-1 and the localization of TIMP-1 to secretory granules are consistent with the hypothesis that, although some TIMP-1 may be secreted, much of it accumulates within the secretory granules of LLCs. This suggestion explains why high TIMP-1 expression during luteal development does not inhibit the rapid pace of neovascularization.
Luteal maintenance
Large luteal cell-derived protease inhibitors may be sequestered within LLCs until they are needed to slow the rate of cell proliferation and migration as the corpus luteum matures. The concentration of TIMP-1 in luteal tissue reaches a plateau before the mid-luteal and late-luteal phase (McIntush and Smith, 1997) , while expression of mRNA encoding TIMP-1 is maintained or increased over the same period (Smith et al., 1994a (Smith et al., , 1996 . These observations indicate that, although TIMP-1 is packaged within secretory granules, it ceases to accumulate. A plateau in TIMP-1 accumulation while production of mRNA encoding TIMP-1 continues indicates that additional TIMP-1 is released. It is interesting to note that the rate of cell proliferation, primarily of endothelial cells associated with neovascularization, begins to plateau in the mid-luteal phase (JablonkaShariff et al., 1993) . Abundant TIMP-1 expression, coupled with accumulation within the developing corpus luteum and increased secretion as the corpus luteum matures, provides an explanation of the mechanism for slowing neovascularization. Tissue inhibitor of metalloproteinases-1 may maintain critical ECM integrity during luteal maintenance. Large luteal cells appear to be the primary cell type responsible for controlling the extent of luteal ECM remodelling since they produce TIMP-1 (Smith et al., 1994a; McIntush et al., 1996) , TIMP-2 (Smith et al., 1995; McIntush et al., 1996) , and plasminogen activator inhibitor-1 (G. W. Smith and M. F. Smith, unpublished) . A distinguishing characteristic of ovine LLCs is the presence of a basal lamina around their periphery except at points of microvillous projections (Farin et al., 1986) . Furthermore, if LLCs are as dependent upon ECM as are mammary epithelial cells, keratinocytes, and hepatocytes (Lin and Bissell, 1993) , then they may produce inhibitors of proteases to preserve their own basal lamina and, in so doing, preserve their differentiated phenotype. The pattern of collagen type IV gene expression in the corpus luteum (Zhao and Luck, 1995) is consistent with the hypothesis that granulosa cells are exposed to some components of basal laminae early in the process of differentiating into LLCs.
Luteolysis
Regression of corpora lutea is marked by loss of cell adhesion to matrix (Nett et al., 1976) , loss of the capacity to synthesize progesterone (Niswender and Nett, 1994) , and apoptosis (Juengel et al., 1993) . Changes in luteal gene expression in response to PGF 2α , the natural luteolysin, are similar to changes in luteal gene expression induced by enzymatic dissociation (G. Niswender, personal communication; Fig. 2 ). Ovine LLCs are the luteal cell type that possess receptors for and respond to PGF 2α . It is proposed that extracellular matrix degradation is an important component of the physiological response of LLCs to PGF 2α , which allows the corpus luteum to regress. In support of this view, microtubules within LLCs disappear within 2 h after administration of PGF 2α (Murdoch, 1996) . These data indicate that contacts between LLCs and the ECM are disrupted during luteal regression. Thus, maintenance of corpora lutea may be dependent upon the establishment and maintenance of contacts between the ECM and LLCs. It is suggested that luteal tissue produces TIMP-1, TIMP-2, TIMP-3 and PAI-1 to preserve the integrity of the ECM components required to maintain the function of luteal cells until the induction of luteolysis.
In humans, the corpus luteum is 'rescued' by hCG during early pregnancy. Although the specific mechanisms associated with luteal rescue are unknown, there is increasing evidence that human granulosa-lutein cells depend on contact with the ECM for cell survival and that hCG decreases gelatinase production (Stamouli et al., 1996) and increases TIMP-1 production (O'Sullivan et al., 1997) . Stabilization of ECM-luteal cell contacts may enhance steroidogenesis and promote cell survival.
If inhibitors of ECM proteases are important for luteal maintenance, then destruction of TIMP-1 may be important for luteal regression. Inactivation of TIMP-1 could be accomplished by mechanisms that have been implicated in luteolysis. For example, leukocytes, which are involved in luteolysis, inactivate TIMP-1 by proteolytic degradation (Itoh and Nagase, 1995) . In addition, highly reactive peroxynitrite, ONOO -(generated by the reaction of superoxide (O 2 ⊄-) with nitric oxide ( ⊄ NO)), which inactivates TIMP-1 (Frears et al., 1996) , may be generated by luteal tissue during the generation of oxygen radicals associated with luteolysis (Sawada and Carlson, 1994) .
Conclusion
In conclusion, growth of an ovarian follicle culminating in ovulation or atresia and the development, maintenance and regression of a corpus luteum are cyclic events that depend upon extensive remodelling of the ECM. Components of the ECM modulate cellular processes (including gene expression; cellular proliferation, migration and differentiation; and apoptosis) via cell surface receptors and serve as a reservoir for a number of biologically active factors. Consequently, the controlled degradation of ECM proteins by MMPs and TIMPs may be essential for preserving a microenvironment conducive to follicular and luteal function.
